IL107400A0 - Bradykinin antagonists - Google Patents

Bradykinin antagonists

Info

Publication number
IL107400A0
IL107400A0 IL107400A IL10740093A IL107400A0 IL 107400 A0 IL107400 A0 IL 107400A0 IL 107400 A IL107400 A IL 107400A IL 10740093 A IL10740093 A IL 10740093A IL 107400 A0 IL107400 A0 IL 107400A0
Authority
IL
Israel
Prior art keywords
bradykinin antagonists
bradykinin
antagonists
Prior art date
Application number
IL107400A
Other languages
English (en)
Original Assignee
Cortech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortech Inc filed Critical Cortech Inc
Publication of IL107400A0 publication Critical patent/IL107400A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL107400A 1992-11-10 1993-10-25 Bradykinin antagonists IL107400A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97400092A 1992-11-10 1992-11-10

Publications (1)

Publication Number Publication Date
IL107400A0 true IL107400A0 (en) 1994-01-25

Family

ID=25521455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107400A IL107400A0 (en) 1992-11-10 1993-10-25 Bradykinin antagonists

Country Status (11)

Country Link
EP (1) EP0671941A4 (xx)
JP (1) JPH08503460A (xx)
CN (1) CN1094058A (xx)
AU (1) AU5410994A (xx)
CA (1) CA2147869A1 (xx)
IL (1) IL107400A0 (xx)
MX (1) MX9306988A (xx)
NZ (1) NZ257477A (xx)
PL (1) PL304654A1 (xx)
WO (1) WO1994011021A1 (xx)
ZA (1) ZA938014B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663401B1 (en) * 1993-07-23 2000-06-07 Toray Industries, Inc. Morphinan derivative and medicinal use
EP0832106A2 (en) * 1995-06-05 1998-04-01 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
US6143719A (en) * 1995-06-09 2000-11-07 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6359111B1 (en) * 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
WO2005032474A2 (en) 2003-09-30 2005-04-14 New River Pharmaceuticals Inc. Pharmaceutical compositions for prevention of overdose or abuse
WO2003020200A2 (en) 2000-11-16 2003-03-13 New River Pharmaceuticals Inc. A novel pharmaceutical compound and methods of making and using same
EP1357928B1 (en) * 2000-11-16 2011-11-16 Shire LLC A novel pharmaceutical compound and methods of making and using same
AU2001297565B2 (en) * 2000-11-16 2008-06-05 Takeda Pharmaceutical Company Limited A novel pharmaceutical compound and methods of making and using same
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7338939B2 (en) 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US7375082B2 (en) 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US7700561B2 (en) 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
AU2003219863C1 (en) 2002-02-22 2009-03-05 Shire Llc Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
AR040956A1 (es) 2002-07-31 2005-04-27 Schering Ag Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
AU2003253365A1 (en) * 2002-07-31 2004-02-23 Schering Ag New effector conjugates, process for their production and their pharmaceutical use
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
WO1992017201A1 (en) * 1991-04-01 1992-10-15 Cortech, Inc. Bradykinin antagonists
SE9101472D0 (sv) * 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist

Also Published As

Publication number Publication date
EP0671941A1 (en) 1995-09-20
CN1094058A (zh) 1994-10-26
AU5410994A (en) 1994-06-08
CA2147869A1 (en) 1994-05-26
ZA938014B (en) 1994-07-11
MX9306988A (es) 1995-01-31
EP0671941A4 (en) 1996-05-29
NZ257477A (en) 1996-07-26
WO1994011021A1 (en) 1994-05-26
JPH08503460A (ja) 1996-04-16
PL304654A1 (en) 1995-01-09

Similar Documents

Publication Publication Date Title
IL105877A0 (en) Angiotensin ii antagonists
EP0586613A4 (en) Bradykinin antagonists
PL304654A1 (en) Bradykinin antagonists
HU9303579D0 (en) Resin-free-succinimides
GB9215405D0 (en) Auto-reclosers
ZA916711B (en) Bradykinin antagonists
ZA932177B (en) TNF-muteins
EP0729472A4 (en) OXYTOCIN ANTAGONISTS COMPRISING PIPERIDINYLCAMPHOSULFONYL
GB9317760D0 (en) Angiotensin ii antagonist
ZA935870B (en) Spray can
GB9317758D0 (en) Angiotensin ii antagonist
HU9501775D0 (en) Substituted 6-azaandrostenones
HU9501695D0 (en) Substituted benzazepinones
SG50426A1 (en) Lhrh antagonists
DE69318966D1 (en) Chemilumineszenzverstärker
GB9204772D0 (en) Workcentre
ZA937403B (en) Substituted carbamoylpyrazolines
ZA937442B (en) Substituted 2-arylpyrroles
GB9306489D0 (en) Oxytocin antagonists
IL120336A0 (en) Angiotensin II antagonists
PL296231A1 (en) Dispergant
GB9218057D0 (en) Pedalok
GB2272920B (en) Construction component
GB9225286D0 (en) Construction component
RU1834966C (ru) Здahиe, coopужehиe